Aug 20, 2026 04:50AM
Jul 29, 2026 11:15AM
Jul 28, 2026 11:15AM
Mar 31, 2026 10:15AM
Feb 5, 2026 10:29AM
Feb 4, 2026 11:02AM
Feb 11, 2025 10:43AM Biogen (BIIB) February 14 weekly option implied volatility into quarter results
Nov 18, 2024 03:09PM
Apr 23, 2024 11:07AM
Feb 13, 2024 04:46PM
Feb 12, 2024 10:54AM
Nov 7, 2023 11:03AM
Jul 28, 2023 11:19AM
Jul 28, 2023 09:17AM Biogen (BIIB) option IV into acquiring Reata Pharmaceuticals (RETA) for $172.50 per share in cash
Jun 13, 2023 04:32PM
Jun 12, 2023 04:04AM
Jun 9, 2023 04:01PM
Jun 9, 2023 04:01PM
Jun 9, 2023 07:35AM
Jun 8, 2023 10:12AM
Jun 8, 2023 07:42AM Biogen (BIIB) option implied volatility flat
Apr 24, 2023 11:05AM
Feb 14, 2023 10:33AM
Jan 9, 2023 03:45AM
Nov 29, 2022 10:15AM
Nov 29, 2022 05:08AM
Nov 28, 2022 10:49AM
Nov 28, 2022 03:57AM Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress
Nov 25, 2022 10:52AM
Nov 25, 2022 04:49AM
Nov 23, 2022 04:05AM
Nov 22, 2022 05:26AM
Nov 21, 2022 04:54AM
Nov 14, 2022 04:57AM
Nov 11, 2022 02:36PM Biogen (BIIB) November option implied volatility at 64, December is at 55
Sep 28, 2022 04:28PM
Sep 28, 2022 04:46AM
Sep 27, 2022 05:04AM
Sep 26, 2022 03:27PM
Sep 22, 2022 10:03AM
Sep 21, 2022 10:33AM
Sep 21, 2022 08:16AM Biogen (BIIB) option implied volatility increases
Sep 19, 2022 09:59AM
Sep 9, 2022 05:32AM
Sep 8, 2022 11:31AM
Sep 8, 2022 04:01AM
Sep 7, 2022 10:38AM
Jul 19, 2022 10:43AM
Jul 18, 2022 10:16AM Biogen (BIIB) option IV at high end of range into quarter results and outlook
May 2, 2022 10:39AM

93,391 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All